NR1I3 inhibits colorectal cancer growth by enhancing PCK1-mediated gluconeogenesis.
NR1I3 inhibits colorectal cancer growth by enhancing PCK1-mediated gluconeogenesis.
2025 · DOI: 10.1016/j.cbi.2025.111734
Chemico-Biological Interactions · 0 Citations
TLDR
It is suggested that NR1I3 inhibits CRC by converting glycolysis to gluconeogenesis via PCK1, suggesting potential indicators and treatment targets for CRC progression.
Log in to view references and citations